Gleneagles Global Hospitals (formerly Global Hospital)

Gleneagles Global Hospitals — formerly known as Global Hospitals — is one of India's most prestigious multi-specialty hospital groups, with flagship facilities in Chennai (Perumbur), Hyderabad (Lakdi Ka Pul), Mumbai (Parel), and Bengaluru (Hebbal). The group is part of the Parkway Pantai / IHH Healthcare network, one of the world's largest hospital groups with operations across Asia, the Middle East, and Europe.

Global Hospitals was founded with a distinctive vision of clinical excellence in organ transplantation and complex tertiary care. The group's liver transplant programme — particularly at the Chennai centre — is among the most active and experienced in South Asia, performing hundreds of cadaveric and living donor liver transplants annually. The programme's outcomes are benchmarked against leading liver transplant programmes globally, with multi-organ transplant cases managed by a multidisciplinary team of transplant surgeons, hepatologists, intensivists, and specialist nurses.

Beyond transplantation, Gleneagles Global Hospitals is renowned for cardiac surgery, oncology, neurosciences, gastroenterology, and orthopaedics. The hospitals draw patients from across India and from over 60 countries, particularly from West Africa, East Africa, the Gulf region, Bangladesh, Nepal, and Southeast Asia. Each facility is a tertiary and quaternary care centre providing advanced medical and surgical services including robotic surgery, minimally invasive procedures, and complex multi-organ operations. The group's strategic positioning within the IHH Healthcare network gives it access to global best practices and clinical governance standards from Singapore and Malaysia.

Gleneagles Global Hospitals' flagship programmes include multi-organ transplantation — with a particular focus on living donor and cadaveric liver transplantation (performing among the highest volumes of liver transplants in India), kidney transplantation (living and deceased donor), heart transplantation, lung transplantation, pancreas transplantation, and simultaneous liver-kidney transplant. Bone marrow transplantation (autologous and allogeneic) is offered for haematological malignancies.

The cardiac surgery and interventional cardiology programme covers coronary artery bypass grafting, valve repair and replacement, complex congenital heart disease surgery, electrophysiology studies and ablation, TAVI (transcatheter aortic valve implantation), and advanced heart failure management including ventricular assist devices. Oncology services include medical oncology with targeted therapy and immunotherapy, surgical oncology across all specialties, radiation oncology with linear accelerator-based treatment, and haemato-oncology including stem cell transplantation.

Additional Centres of Excellence include hepato-pancreato-biliary (HPB) surgery, neurosciences, orthopaedics and joint replacement, gastroenterology and advanced endoscopy, nephrology, urology and robotic urology, gynaecological oncology, and neonatology. A dedicated sickle cell disease and thalassaemia management programme is available for patients from Africa who present with these haematological conditions.

Gleneagles Global Hospitals operates highly specialised facilities across its multi-city network. For transplant services, the hospitals maintain dedicated organ transplant operation theatres with advanced perfusion systems, transplant-specific ICUs with isolation capacity, HLA typing and crossmatch laboratories for donor-recipient matching, a specialised liver function monitoring laboratory, and hepatology outpatient services supporting pre- and post-transplant patient care.

General surgical facilities include multiple modular operation theatres, da Vinci robotic surgery system, hybrid operating theatres for complex cardiovascular and endovascular procedures, advanced laparoscopic systems, and thoracoscopic equipment. Diagnostic imaging capabilities include 3T MRI, 128-slice CT, PET-CT for oncological staging and liver transplant evaluation, SPECT-CT, digital fluoroscopy, and ultrasound-guided interventional radiology.

ICU infrastructure includes medical and surgical ICUs, cardiac ICU, transplant ICU, and neonatal ICU (NICU), each with 24-hour specialist cover and advanced monitoring. Blood bank services include apheresis for stem cell collection, irradiated blood products for transplant patients, and platelet pheresis. The clinical laboratory is NABL-accredited with molecular diagnostics capability for transplant-related infectious disease monitoring.

Gleneagles Global Hospitals has a well-developed international patient services programme with dedicated international patient coordinators experienced in managing complex cases for patients from over 60 countries. The hospitals serve a particularly large cohort of patients from West Africa (Nigeria, Ghana, Sierra Leone, Senegal), East Africa (Kenya, Tanzania, Uganda, Ethiopia, Rwanda), the Gulf region (UAE, Saudi Arabia, Kuwait, Bahrain), Bangladesh, Nepal, Sri Lanka, Afghanistan, and Southeast Asia.

For international patients, services include pre-arrival specialist teleconsultation with organ transplant surgeons, cardiologists, oncologists, and other specialists, review of all overseas medical records and imaging, detailed cost estimates for transplant and other procedures, medical visa invitation letters, airport transfer from Chennai, Hyderabad, Mumbai, or Bengaluru airports, accommodation coordination for patients and their caregivers during extended transplant recovery, FRRO registration assistance for long-stay patients, and comprehensive English-language discharge documentation.

Organ transplant services for international patients in India are subject to the Transplantation of Human Organs and Tissues Act (THOTA) regulations. International patients are strongly advised to contact the hospital's transplant coordination team directly for current guidance on eligibility and regulatory requirements before planning travel to India for transplant procedures.

Gleneagles Global Hospitals hold NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditation across their facilities, ensuring comprehensive clinical quality governance. The hospitals are part of IHH Healthcare / Parkway Pantai, which applies international quality management standards across its global hospital network.

The liver transplant programme is registered with appropriate state government authorities and the National Organ and Tissue Transplant Organisation (NOTTO) of India. The bone marrow transplant programme is recognised by the NMDP (National Marrow Donor Program) and Bone Marrow Donors Worldwide (BMDW). Quality outcomes for organ transplant programmes including graft survival rates, patient survival rates, and complication rates are monitored against national and international benchmarks.

The hospitals' specialists include transplant surgeons with training at leading centres in the USA, UK, and Europe. Senior liver transplant surgeons hold FRCS qualifications and have training from King's College Hospital London, University of Pittsburgh, and other globally recognised transplant centres. The Chennai facility has received recognition from ILTS (International Liver Transplantation Society) for its programme quality.